Rohto Pharmaceutical Joins 'ASAGI Labs Longevity Consortium'

Rohto Pharmaceutical has joined the 'ASAGI Labs Longevity Consortium' established by ASAGI Labs. By leveraging its expertise in cell research and consumer touchpoints, the company aims to extend healthy life expectancy and create new longevity solutions.
healthNQ 49/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: June 2, 2026 at 00:00
  • 🔍 Collected: June 1, 2026 at 15:20
  • 🤖 AI Analyzed: June 1, 2026 at 18:06 (2h 45m after Collected)
Rohto Pharmaceutical Co., Ltd. is pleased to announce its participation in the 'ASAGI Labs Longevity Consortium,' established by the general incorporated foundation ASAGI Labs, which will begin full-scale activities on June 1, 2026. The 'ASAGI Labs Longevity Consortium' is a co-creation platform where diverse stakeholders such as academia, companies, local governments, hospitals/clinics, and non-profit organizations collaborate to promote research and development, business creation, and social implementation related to longevity. With a focus on extending healthy life expectancy, sustainable social participation, life planning based on individual narratives, and responding to multi-stage lives, the consortium aims to create Japan-originated longevity solutions. Since its founding, Rohto has been involved in various fields related to the human body and daily life, such as eye drops, gastrointestinal medicines, skincare, food, and regenerative medicine, and has sincerely faced the challenge of 'people living long and healthy lives.' Rohto's concept of longevity is to maximize health through science and make life long and enjoyable. The starting point lies in understanding the mechanisms of the human body itself. We have captured the body in a multi-layered structure of cells, tissues, and organs, and have honed our fundamental technologies centered on cell research for many years. Based on this research foundation, we aim to capture longevity from a scientific perspective and implement its value in society in a way that reaches consumers. Through this participation, we will leverage our consumer touchpoints cultivated through eye care, skincare, oral medicines, food, and regenerative medicine to engage in issue exploration, joint research, and demonstration activities related to longevity. Furthermore, we will challenge ourselves to create new value for the social implementation of longevity through co-creation with diverse partners such as academia, companies, local governments, and medical institutions.

FAQ

What is Rohto's approach to longevity?

Leveraging cell research knowledge to implement solutions that maximize health.